SAMSUNG PHARM Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.2%.

Top 13 shareholders own 15.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	GemVax&KAEL Co.,Ltd.	9,852,179	₩15.4b	0%	no data
3.54%	The Vanguard Group, Inc.	3,332,849	₩5.2b	4.47%	no data
0.61%	Dimensional Fund Advisors LP	573,996	₩897.2m	1.98%	no data
0.41%	Norges Bank Investment Management	385,721	₩602.9m	0%	no data
0.05%	State Street Global Advisors, Inc.	46,864	₩73.2m	-1%	no data
0.0057%	Mirae Asset Global Investments Co., Ltd.	5,351	₩8.4m	0%	no data
0.0047%	Kyungpyo Jung	4,447	₩6.9m	0%	no data
0.0041%	KB Asset Management Co., Ltd.	3,864	₩6.0m	0%	no data
0.0023%	Samsung Asset Management Company, Ltd.	2,148	₩3.4m	0%	no data
0.0019%	Bong-Kwon Park	1,748	₩2.7m	0%	no data
0.0011%	Invesco Capital Management LLC	995	₩1.6m	0%	no data
0.00077%	American Century Investment Management Inc	726	₩1.1m	0.41%	no data
0.00024%	Korea Investment Management Co., Ltd.	230	₩353.1k	0%	no data